Published in Mediators Inflamm on July 15, 2013
Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci (2014) 0.97
Association of TNFα(-308), IFNγ(+874), and IL10(-1082) gene polymorphisms and the risk of non-small cell lung cancer in the population of the South Indian state of Telangana. Int J Clin Oncol (2016) 0.90
Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta (2014) 0.84
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2015) 0.80
The discordant method: a novel approach for differential correlation. Bioinformatics (2015) 0.78
Can we predict the prognosis of COPD with a routine blood test? Int J Chron Obstruct Pulmon Dis (2017) 0.77
DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine. J Immunol (2015) 0.77
Urinary neutrophil gelatinase-associated lipocalin is associated with heavy metal exposure in welding workers. Sci Rep (2015) 0.77
Smoking, inflammation and small cell lung cancer: recent developments. Wien Med Wochenschr (2015) 0.77
The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul) (2015) 0.76
T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea. Mediators Inflamm (2015) 0.76
TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice. Am J Physiol Lung Cell Mol Physiol (2016) 0.76
Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.75
The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ. Clin Exp Med (2015) 0.75
Post-GWAS Prioritization Through Data Integration Provides Novel Insights on Chronic Obstructive Pulmonary Disease. Stat Biosci (2016) 0.75
Wellbeing and chronic lung disease incidence: The Survey of Health, Ageing and Retirement in Europe. PLoS One (2017) 0.75
Time Course of the Phenotype of Blood and Bone Marrow Monocytes and Macrophages in the Lung after Cigarette Smoke Exposure In Vivo. Int J Mol Sci (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
A role for mitochondria in NLRP3 inflammasome activation. Nature (2010) 13.21
Autophagy in immunity and inflammation. Nature (2011) 11.16
An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature (2007) 10.92
Interleukin-17 and type 17 helper T cells. N Engl J Med (2009) 6.83
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol (2008) 6.56
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol (2007) 6.36
Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 6.23
Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med (2011) 4.78
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med (2008) 4.33
Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med (2009) 4.27
Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem (1994) 4.17
Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe (2008) 4.14
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol (2003) 3.47
The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 3.36
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol (2007) 3.06
Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med (2007) 3.05
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med (2010) 2.85
Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol (2008) 2.83
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol (2006) 2.57
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J (2008) 2.51
Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 2.45
CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.30
The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One (2012) 2.28
Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol (2005) 2.28
Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med (1995) 2.24
The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.23
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.21
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med (2005) 2.09
Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med (2006) 2.05
Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04
Molecular pathogenesis of emphysema. J Clin Invest (2008) 2.03
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.94
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol (2009) 1.89
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am J Respir Crit Care Med (2009) 1.86
Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med (2007) 1.79
Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J (2011) 1.76
State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc (2006) 1.75
Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. J Immunol (2006) 1.73
Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med (2000) 1.70
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2010) 1.69
Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.63
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med (2010) 1.59
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol (2002) 1.53
Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest (2002) 1.52
Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One (2012) 1.51
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax (2002) 1.51
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.49
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol (2008) 1.43
NALP3: a key player in caspase-1 activation. J Endotoxin Res (2006) 1.42
IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One (2011) 1.37
Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J (2011) 1.37
Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med (2007) 1.34
IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol (2007) 1.34
P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One (2011) 1.33
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med (2005) 1.30
Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.30
Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2009) 1.28
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax (2003) 1.26
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax (2002) 1.26
Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc (2008) 1.26
Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J (2009) 1.25
Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema. J Immunol (2008) 1.24
Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med (1994) 1.20
Interleukin-18 production and pulmonary function in COPD. Eur Respir J (2007) 1.19
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med (2011) 1.19
IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13. Am J Respir Crit Care Med (2012) 1.18
Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol (2006) 1.12
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol (2010) 1.11
Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med (2006) 1.10
Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung (2007) 1.09
Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. Am J Respir Crit Care Med (2010) 1.08
Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J (2005) 1.08
Smoke exposure as a determinant of autoantibody titre in α₁-antitrypsin deficiency and COPD. Eur Respir J (2010) 1.02
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res (2013) 0.97
Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. Respir Res (2010) 0.96
Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci (2009) 0.95
Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax (2010) 0.95
ATP in the pathogenesis of lung emphysema. Eur J Pharmacol (2009) 0.95
Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Respir Med (2009) 0.94
Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in mice. Respir Res (2012) 0.94
The role of the NLRP3 inflammasome in the pathogenesis of airway disease. Pharmacol Ther (2011) 0.93
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD. Respir Res (2013) 0.91
Association of severity of COPD with IgE and interleukin-1 beta. Monaldi Arch Chest Dis (2010) 0.90
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J (2012) 0.89
Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax (2012) 0.86
Role of IL-18 in second-hand smoke-induced emphysema. Am J Respir Cell Mol Biol (2013) 0.84
Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD. Eur J Clin Invest (2011) 0.83
Effect of NF‑κB inhibitor on high‑mobility group protein B1 expression in a COPD rat model. Mol Med Rep (2012) 0.83
Interleukin-1beta targeted therapy in severe persistent asthma (SPA) and chronic obstructive pulmonary disease (COPD): proposed similarities between biphasic pathobiology of SPA/COPD and ischemia-reperfusion injury. Isr Med Assoc J (2008) 0.82
Effects of mechanical ventilation at low lung volume on respiratory mechanics and nitric oxide exhalation in normal rabbits. J Appl Physiol (1985) (2005) 1.54
Plasma membrane disruptions with different modes of injurious mechanical ventilation in normal rat lungs*. Crit Care Med (2012) 1.45
Acute effects of combined high-frequency oscillation and tracheal gas insufflation in severe acute respiratory distress syndrome. Crit Care Med (2007) 1.45
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respir Med (2009) 1.03
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med (2007) 0.92
Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery. Acta Neurochir (Wien) (2009) 0.91
Successful resuscitation with thrombolysis of a patient suffering fulminant pulmonary embolism after recent intracerebral haemorrhage. Resuscitation (2006) 0.87
Cytokine release, small airway injury, and parenchymal damage during mechanical ventilation in normal open-chest rats. J Appl Physiol (1985) (2007) 0.86
Effects of exercise-induced arterial hypoxaemia and work rate on diaphragmatic fatigue in highly trained endurance athletes. J Physiol (2006) 0.85
Primary choriocarcinoma of the renal pelvis presenting as intracerebral hemorrhage: a case report and review of the literature. J Med Case Rep (2011) 0.84
Pathophysiology of evolution of small airways disease to overt COPD. COPD (2010) 0.82
Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med (2010) 0.81
Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma. Respir Med (2013) 0.81
Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis. Anesthesiology (2011) 0.80
Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking. Eur J Clin Invest (2015) 0.79
Effects of interval-load versus constant-load training on the BODE index in COPD patients. Respir Med (2009) 0.79
Driving-Related Neuropsychological Performance in Stable COPD Patients. Pulm Med (2013) 0.78
Role of quantitative CT in predicting postoperative FEV1 and chronic dyspnea in patients undergoing lung resection. Multidiscip Respir Med (2010) 0.78
Dyspnea and respiratory muscle strength in end-stage liver disease. World J Hepatol (2013) 0.77
Effects of various modes of mechanical ventilation in normal rats. Anesthesiology (2014) 0.76
Turn the ARDS patient prone to improve oxygenation and decrease risk of lung injury. Intensive Care Med (2004) 0.75
Postoperative parotid abscess: another occult source of severe sepsis. Surg Infect (Larchmt) (2013) 0.75
Cerebral vein thrombosis after coronary artery bypass surgery. Interact Cardiovasc Thorac Surg (2007) 0.75
Changes in BODE Quartiles After Pulmonary Rehabilitation Do Not Predict 2-Year Survival in Patients With COPD. J Cardiopulm Rehabil Prev (2015) 0.75
Latest therapeutic novelties and patents in pulmonary hypertension. Recent Pat Cardiovasc Drug Discov (2011) 0.75
Effect of rehabilitative exercise training on peripheral muscle remodelling in patients with COPD: targeting beyond the lungs. Curr Drug Targets (2013) 0.75
History of mechanical ventilation may affect respiratory mechanics evolution in acute respiratory distress syndrome. J Crit Care (2009) 0.75
Pleural fluid glucose: A predictor of unsuccessful pleurodesis in a preselected cohort of patients with malignant pleural effusion. J BUON (2014) 0.75